Managing Severe Hypertriglyceridemia: Best Practices and New Approaches

Severe hypertriglyceridemia poses significant health risks, including acute pancreatitis and cardiovascular disease, necessitating effective management strategies. This session, "Managing Severe Hypertriglyceridemia: Best Practices and New Approaches," will provide an in-depth exploration of current and emerging strategies for managing this complex condition.We will start by reviewing established best practices in the management of severe hypertriglyceridemia, including lifestyle modifications, dietary interventions, and pharmacological therapies. Emphasis will be placed on the latest guidelines, evidence-based approaches to optimizing treatment.The session will also delve into new and innovative therapies, such as olezarsan and their potential impact on familial chylomicronemia syndrome (FCS) patient outcomes.